Who owns United Therapeutics (UTHR)? Superinvestor holders
4 superinvestors of the 157 tracked here hold United Therapeutics (UTHR) in their latest 13F filing, with $1.4B between them. Jim Simons (1938–2024) gives it the most weight: 1.24% of the reported portfolio. In their latest reported quarter, Ray Dalio (founder) and Israel Englander added; Jim Simons (1938–2024) and Baillie Gifford team reduced.
David Shaw (founder) sold out of it in their latest quarter.
Key facts
- Superinvestors holding it
- 4 of 157
- Biggest holder
- Jim Simons (1938–2024), $908.2M
- Largest weight
- Jim Simons (1938–2024), 1.24%of their portfolio
- Combined value
- $1.4B
- Bought last quarter
- 2
- Sold last quarter
- 3
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Jim Simons (1938–2024)Renaissance Technologies | 1.24% | $908.2M | 1.68M | ▼ Reduced 1.9% | −32.81K | Q3 2026 |
| 2 | Ray Dalio (founder)Bridgewater Associates | 0.25% | $60.3M | 111.33K | ▲ Added 0.1% | +156 | Q2 2026 |
| 3 | Baillie Gifford teamBaillie Gifford & Co | 0.19% | $205.4M | 379.1K | ▼ Reduced 19% | −88.12K | Q3 2026 |
| 4 | Israel EnglanderMillennium Management | 0.15% | $221.6M | 409.07K | ▲ Added 167% | +255.7K | Q2 2026 |
Sold out last quarter
- David Shaw (founder)was $58.8M · Q2 2026
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 2 | 2.05M | $1.1B | 0 | 2 |
| Q2 2026 | 157 | 5 | 2.96M | $1.6B | 3 | 4 |
| Q1 2026 | 157 | 7 | 3.99M | $2.4B | 4 | 3 |
| Q4 2025 | 157 | 6 | 4.07M | $2B | 3 | 3 |
| Q3 2025 | 157 | 4 | 3.93M | $1.6B | 1 | 5 |
| Q2 2025 | 157 | 6 | 4.54M | $1.3B | 4 | 1 |
| Q1 2025 | 156 | 6 | 4.2M | $1.3B | 3 | 2 |
| Q4 2024 | 156 | 6 | 4.14M | $1.5B | 3 | 2 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Jim Simons (1938–2024) | 1.68M | 1.71M | 1.79M | 1.91M | 2.17M | 2.12M | 2.11M | 2.09M |
| Baillie Gifford team | 379.1K | 467.21K | 428.13K | 323.02K | — | — | — | — |
| Israel Englander | · | 409.07K | — | — | — | — | — | — |
| Josef Lakonishok | — | 268.37K | 398.67K | 408.07K | 686.71K | 864.62K | 902.32K | 908.72K |
| Ray Dalio (founder) | · | 111.33K | 111.17K | 64.6K | — | 195.12K | 193.78K | 107.73K |
| Cliff Asness | · | — | 826.23K | 1.28M | 986.48K | 1.27M | 908.45K | 975.44K |
| Ken Griffin | · | — | 360.64K | — | — | — | — | — |
| Joel Greenblatt | · | — | 80.39K | 80.02K | 80.96K | 89.4K | 89.34K | 61.18K |
| Andrew Spokes | — | — | — | — | — | 1K | 1K | 1K |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own UTHR?
In their latest 13F filings: Jim Simons (1938–2024) (1.24% of the portfolio, $908.2M), Ray Dalio (founder) (0.25% of the portfolio, $60.3M), Baillie Gifford team (0.19% of the portfolio, $205.4M), Israel Englander (0.15% of the portfolio, $221.6M).
Who bought UTHR last quarter?
Ray Dalio (founder) (added 0.1%), Israel Englander (added 167%). “Last quarter” is each investor's latest reported quarter.
Who sold UTHR last quarter?
Reduced: Jim Simons (1938–2024) (1.9% fewer shares), Baillie Gifford team (19% fewer shares). Sold out entirely: David Shaw (founder) (was $58.8M).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns United Therapeutics (UTHR)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/UTHR/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to UTHR by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.